We have highlighted eight novel loci, including the genes HDAC4, SYNE2, and most notably GPRC5A, where quite large samples of melanoma cases or nevus count were not sufficiently powerful to reach formal genome-wide significance in univariate analyses, but the combined evidence is conclusive. The gene discussed is SYNE2; the disease is nevus.